✦ LIBER ✦

Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma

✍ Scribed by Bruno Vincenzi; Daniele Santini; Annalisa La Cesa; Giuseppe Tonini

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 54 KB
Volume: 100
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20194

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic acid delays the onset of skel

Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma

✍ Allan Lipton; Ming Zheng; John Seaman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to assess the efficacy and safety of zoledronic acid in patients with bone metastases secondary to renal cell carcinoma (RCC). ## METHODS A retrospective subset analysis of patients with RCC enrolled in a multicenter, randomized, placebo‐

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors

✍ Tawee Tanvetyanon 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma : A randomized, double-blind, multicenter, comparative trial

✍ Lee S. Rosen; David Gordon; Mary Kaminski; Anthony Howell; Andrew Belch; John Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## BACKGROUND The goal of the current study was to compare the long‐term (25‐month) safety and efficacy of zoledronic acid with pamidronate in patients with bone lesions secondary to advanced breast carcinoma or multiple myeloma. ## METHODS Patients (__n__ = 1648) were randomized to

Independent value of tumor size and DNA

Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma

✍ Franco Di Silverio; Paolo Casale; Dario Colella; Loreto Andrea; Fulvia Seccarecc 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## BACKGROUND. Greater than 20% of patients with apparently localized renal cell carcinoma (RCC) present with disease progression after surgery. The objective of the current study was to improve the ability of clinicians to predict prognosis in patients with localized RCC. ## METHODS. The authors

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors : A randomized, Phase III, double-blind, placebo-controlled trial

✍ Lee S. Rosen; David Gordon; N. Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

Phase I trial of interferon α2b and lipo

Phase I trial of interferon α2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma

✍ Jonathan S. Goldberg; Manuel Vargas; Alyssa S. Rosmarin; Matthew I. Milowsky; Ni 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

## Abstract ## BACKGROUND Studies suggest that retinoic acid (RA) can augment the antitumor effects of interferon‐based therapy in patients with advanced renal cell carcinoma (RC); however, this benefit has not been achieved convincingly using oral formulations of 13‐cis RA and all‐__trans__ RA. L